ImmuneSense™ IBD Study

Clinical trial NCT05769829 · TERMINATED

Trial details

NCT number: NCT05769829
Sponsor: Adaptive Biotechnologies
Status: TERMINATED
Study type: OBSERVATIONAL

Inflammatory Bowel Diseases

Start date: 2022-10-31
Primary completion: 2023-08-14
Enrollment: 484

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.